Skip to main content

Table 6 Lipid profile and oxLDL response to atorvastatin treatment (20 mg/day) according to apolipoprotein B (ApoB) rs676210 polymorphism in the patients with CAD

From: ApoB gene polymorphism (rs676210) and its pharmacogenetics impact on atorvastatin response among Iraqi population with coronary artery disease

Parameters Genotype (mean+SD)
G/G (n = 24) G/A (n = 13) A/A (n = 15) P value
TC (mg/dl) 270.71±78.63 294.11±52.64 273.81±78.97 0.76
TG (mg/dl) 151.14±41.61 145.00±31.37 156.36±45.49 0.83
HDL (mg/dl) 50.71±3.40 48.22±1.78 46.63±2.76b 0.01
LDL (mg/dl) 195.81±72.95 216.88±47.06 208.78±66.65 0.80
VLDL (mg/dl) 30.22±8.32 29.00±6.27 31.27±9.09 0.82
oxLDL (U/L) 82.90±29.01 78.72±18.24 77.58±26.16 0.90
  1. ANOVA significance test (2-tailed)
  2. bP ˂ 0.05 GG group vs. AA group